- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04051138
The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability
January 25, 2021 updated by: ChampionsEdge, LLC
This study is designed to compare the effect of Voxx/eSmartr technology on common measures of sports vision performance including (Hand-Eye Coordination/Reaction time, visual concentration and basic visual functions of size detection and contrast sensitivity).
The study will be a randomized, prospective, double-blind design in order to determine the effect of this technology on a subject's sports vision ability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10019
- SportsVisionNYC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria.
- Female or Male age 18-45 years of age
- Exercises at least once a week by self-report
- Physically able to complete the HEC/RT test (e.g. no shoulder or arm discomfort or limitation
Exclusion Criteria.
- Member of a vulnerable population
- Visual or physical condition which precludes performing the physical or visual testing (e.g. strabismus, double vision, shoulder or arm pain or injury)
- Previous training in hand-eye coordination/reaction time or visual concentration
- History of double vision or strabismus
- Insufficient vision to drive an automobile in NY State
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Triple
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CoreScore
Time Frame: 1 day
|
A measure of visual function scored on a linear scale fro +5 to -5, more positive scores are better
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hand-Eye Coordination/Reaction Time
Time Frame: 1 day
|
A measure of how fast the subject reacts to a visual target with their hand, scored on milliseconds, faster the better
|
1 day
|
Neurotracker score
Time Frame: 1 day
|
A measure of how correctly the subject can track multiple objects, scored from 0 to 5 with higher score being better
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel M Laby, MD, ChampionsEdge, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2019
Primary Completion (Actual)
October 30, 2019
Study Completion (Actual)
October 30, 2019
Study Registration Dates
First Submitted
August 5, 2019
First Submitted That Met QC Criteria
August 7, 2019
First Posted (Actual)
August 9, 2019
Study Record Updates
Last Update Posted (Actual)
January 27, 2021
Last Update Submitted That Met QC Criteria
January 25, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- Voxx1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision, Binocular
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)CompletedDiplopia | Binocular Vision Suppression | Binocular; Fusion, With Defective Stereopsis | Monocular DiplopiaUnited States
-
Universitat Politècnica de CatalunyaRecruitingVision Disorders | Binocular Vision Disorder | Eye; Movement Disorder (Binocular) | Vision TherapySpain
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruitingBinocular Vision DisorderChina
-
University Hospital, BrestCompletedVisual Impairment | Binocular Vision DisorderFrance
-
Sierra NeurovisionCEISO; Institut des Sciences de la VisionNot yet recruitingBinocular Vision Disorder | Binocular Eye Movement Disorder | Ocular Motion; DisorderFrance
-
University of WaterlooMcGill University; Retina Foundation of the Southwest; Queensland University...CompletedAmblyopia | Binocular Vision DisorderUnited States, Australia
-
Vision Specialists of BirminghamEssilor InternationalTerminatedVertical Heterophoria | Binocular Dysfunction | Vision, Binocular | Vision DisparityUnited States
-
NHS Greater Glasgow and ClydeUniversity of WaterlooUnknownStrabismus | Vision Disorders | Binocular Vision Disorder | NystagmusUnited Kingdom
-
National Eye Institute (NEI)UnknownConvergence Insufficiency | Binocular Vision DisorderUnited States
-
Vision Specialists of BirminghamSaint Joseph Mercy Health SystemCompletedBinocular Vision Dysfunction | Vertical HeterophoriaUnited States
Clinical Trials on Voxx socks and sleeves
-
Arash Asher, MDVoxxLifeRecruitingNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
University of Texas Southwestern Medical CenterHologenix, LLCTerminatedDiabetic Foot UlcerUnited States
-
Mahidol UniversityWithdrawn
-
Mahidol UniversityCompleted
-
Mahidol UniversityCompletedFoot Dermatoses | Zinc OxideThailand
-
Muğla Sıtkı Koçman UniversityCompleted
-
Firstkind LtdLoughborough UniversityCompletedDelayed Onset Muscle SorenessUnited Kingdom
-
Radboud University Medical CenterWithdrawnHCVNetherlands, Germany
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedLiver Diseases | Hepatitis C | HIV-1-infectionUnited States, Uganda, Brazil, Puerto Rico, South Africa, Thailand